- Filed
- Apr 30, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 102.7M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 102.5M sh |
| Shares Outstanding | Q1 2026 · Mar 31, 2026 | 102.01M sh |
| Dividends Paid | Q1 2026 · Mar 31, 2026 | $83M |
| Dividends Paid | Q1 2026 · Mar 31, 2025 | $75M |
| Capex | Q1 2026 · Mar 31, 2026 | $78M |
| Capex | Q1 2026 · Mar 31, 2025 | $71M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $280M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | $247M |
| Long Term Debt | Q1 2026 · Mar 31, 2026 | $3.33B |
| Long Term Debt | Q1 2026 · Dec 31, 2025 | $3.32B |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $150M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $54M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $4.75B |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $4.74B |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $321M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $296M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $5.26B |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $5.2B |
| Current Assets | Q1 2026 · Mar 31, 2026 | $404M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $318M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $10.16B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $10.08B |
| Total Assets restated | Q1 2026 · Mar 31, 2025 | $10.08B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $1.27 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | $1.06 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $1.28 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | $1.07 |
| Net Income | Q1 2026 · Mar 31, 2026 | $130M |
| Net Income | Q1 2026 · Mar 31, 2025 | $108M |
| Operating Income | Q1 2026 · Mar 31, 2026 | $166M |
| Operating Income | Q1 2026 · Mar 31, 2025 | $148M |
| Revenue | Q1 2026 · Mar 31, 2026 | $336M |
| Revenue | Q1 2026 · Mar 31, 2025 | $303M |